[{"id":"molecular-cancer-therapeutics","kind":"journal","name":"Molecular Cancer Therapeutics","route":"/journals/molecular-cancer-therapeutics/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/journals.ts","type":"changed","fields":[{"field":"summary","before":"\"Monthly. Publishes preclinical pharmacology of new agents (including many ADC payload and linker studies), mechanism-of-action and resistance work, and companion-biomarker development. Hybrid access.\"","after":"\"Molecular Cancer Therapeutics appears monthly and publishes preclinical pharmacology of new agents (including many ADC payload and linker studies), mechanism-of-action and resistance work, and companion-biomarker dev..."}]},{"id":"molecular-cancer-therapeutics","kind":"journal","name":"Molecular Cancer Therapeutics","route":"/journals/molecular-cancer-therapeutics/","commit":"3d932e7abd","date":"2026-09-09","author":"Jude Gomila","message":"Journals: records for every venue cited by key papers","file":"src/data/journals.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"aka"},{"field":"matchNames"},{"field":"publisher"},{"field":"society"},{"field":"url"},{"field":"issn"},{"field":"scope"},{"field":"access"},{"field":"founded"},{"field":"tldr"},{"field":"summary"},{"field":"links"},{"field":"institutions"},{"field":"technologies"}]}]